Global Neurology Clinical Trials Industry concentrated on Huntington's disease is expected to witness a 6.3% CAGR by 2032 | Future Market Insights fmiblog.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fmiblog.com Daily Mail and Mail on Sunday newspapers.
In the fiscal year 2023, the global Parkinson’s disease market is poised to reach an impressive valuation of US$ 5.41 Billion, marking a significant rise from US$ 4.82 Billion in the previous fiscal year, 2022. Projections for the period from 2023 to 2033 indicate a robust and consistent growth pattern, with an anti.
In the year 2022, the global Parkinson’s Disease Market was estimated to be worth US$ 4.82 Billion. Considering the rising demand in the global market, it is predicted to reach a valuation of US$ 5.41 Billion by 2023. The market will also exhibit a steady CAGR of 12.2% from 2023-2033 and hence ultimately reach US$ 1.
PALM BEACH, Fla., June 7, 2022 /PRNewswire/ FinancialNewsMedia.com News Commentary - The global Central Nervous System (CNS) treatments and its market revenues had been steadily growing pre-pandemic